Pentoxifylline in the Treatment of Cutaneous Leishmaniasis: A Randomized Clinical Trial in Colombia

Pentoxifylline in the Treatment of Cutaneous Leishmaniasis: A Randomized Clinical Trial in Colombia

Addition of the immunomodulator pentoxifylline (PTX) to antimonial treatment of mucosal leishmaniasis has shown increased efficacy. This randomized, double-blind, placebo-controlled trial evaluated whether addition of pentoxifylline to meglumine antimoniate (MA) treatment improves therapeutic respon...

Full description

Bibliographic Details
Main Authors:	Maria del Mar Castro, Alexandra Cossio, Adriana Navas, Olga Fernandez, Liliana Valderrama, Lyda Cuervo-Pardo, Ricardo Marquez-Oñate, María Adelaida Gómez, Nancy Gore Saravia
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Pathogens
Subjects:	cutaneous leishmaniasis pentoxifylline meglumine antimoniate clinical trial
Online Access:	https://www.mdpi.com/2076-0817/11/3/378

Similar Items

Treatment of cutaneous leishmaniasis with combination of allopurinol and low dose of meglumine antimoniate
by: A Momeni, et al.
Published: (2001-03-01)

Comparison of Intralesional Meglumine Antimoniate Plus Oral Allopurinol with Intralesional Meglumine Antimoniate Alone for the Treatment of Cutaneous Leishmaniasis- A Prospective Study
by: Nida Qayyum, et al.
Published: (2024-05-01)

Warning against increasing cases of cutaneous leishmaniasis and unavailability of meglumine in Pakistan
by: Sadia Iram, et al.
Published: (2023-12-01)

RESOLUTION OF CUTANEOUS LEISHMANIASIS AFTER ACUTE ECZEMA DUE TO INTRALESIONAL MEGLUMINE ANTIMONIATE
by: Erica de Camargo Ferreira e Vasconcellos, et al.
Published: (2014-07-01)

The Additive Effect of Topical Ciprofloxacin 2% on Intralesional Glucantime Injection in Treatment of Cutaneous Leishmaniasis
by: Mohamadjavad Yazdanpanah, et al.
Published: (2020-06-01)

Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre
by: Rosiana Estéfane da Silva, et al.
Published: (2016-08-01)

Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial
by: Dario Brock Ramalho, et al.
Published: (2018-06-01)

The Efficacy of Carbon Dioxide Laser in the Treatment of Chronic and Lupoid Cutaneous Leishmaniasis in Kerman City: A Randomized Clinical Trial
by: I Esfandiarpour, et al.
Published: (2014-07-01)

Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment
by: Rosiana Estéfane da Silva, et al.

PANCREATIC TOXICITY AS AN ADVERSE EFFECT INDUCED BY MEGLUMINE ANTIMONIATE THERAPY IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS
by: Marcelo Rosandiski LYRA, et al.

The Efficacy, Relapse and Failure in the Treatment of Anthroponotic Cutaneous Leishmaniosis with Intralesional Glucantime Along with Cryotherapy
by: Mehran Karvar, et al.
Published: (2016-03-01)

The Efficacy of Intralesional Meglumine Antimoniate (Glucantime) versus a Combination of Topical Trichloroacetic Acid 50% and Local Heat Therapy by Non-Ablative Radiofrequency on Cutaneous Leishmaniasis Lesions
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2011-12-01)

A Promising Cutaneous Leishmaniasis Treatment with a Nanoemulsion-Based Cream with a Generic Pentavalent Antimony (Ulamina) as the Active Ingredient
by: Johnny Bullón, et al.
Published: (2021-12-01)

Treatment of Canine Leishmaniasis with Meglumine Antimoniate: A Clinical Study of Tolerability and Efficacy
by: Serena Digiaro, et al.
Published: (2024-08-01)

High and low doses of antimony (Sb v) in American cutaneous leishmaniasis: a five years follow-up study of 15 patients
by: MP Oliveira-Neto, et al.
Published: (1996-04-01)

Pentavalent Antimony Associated with G-CSF in the Treatment of Cutaneous Leishmaniasis Caused by <i>Leishmania (Viannia) braziliensis</i>
by: Carvel Suprien, et al.
Published: (2024-04-01)

Preparation and Evaluation of Clinical Effects of Glucantime Gel Mask
by: Sayed Abolfazl Mostafavi, et al.
Published: (2013-06-01)

Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)
by: Lucia Regina Brahim, et al.

Comparison between topical treatment with thioxolone , benzoxonium chloride tincture and intralesional injection of meglumine antymoniate on cutaneous leishmaniasis
by: M.H Daei-Parizi, et al.
Published: (1995-12-01)

FACTORS ASSOCIATED TO ADHERENCE TO DIFFERENT TREATMENT SCHEMES WITH MEGLUMINE ANTIMONIATE IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS
by: Madelon Novato Ribeiro, et al.
Published: (2014-07-01)

Hypersensitivity eosinophilic myocarditis possibly triggered by meglumine antimoniate
by: Sergio A. Bolivar-Lozano, et al.
Published: (2024-03-01)

NEPHROTOXICITY ATTRIBUTED TO MEGLUMINE ANTIMONIATE (GLUCANTIME) IN THE TREATMENT OF GENERALIZED CUTANEOUS LEISHMANIASIS
by: M.L.O. RODRIGUES, et al.
Published: (1999-01-01)

Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil Azitromicina para tratamento de leishmaniose cutânea em Manaus, AM, Brasil
by: Alan César Teixeira, et al.
Published: (2007-08-01)

In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis
by: Eliane de Morais-Teixeira, et al.
Published: (2008-06-01)

Action of pentoxifylline on experimental cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis
by: Thiago de Sá Oliveira, et al.
Published: (2000-08-01)

In Vitro Reduced Susceptibility to Pentavalent Antimonials of a <i>Leishmania infantum</i> Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy
by: Aurora Diotallevi, et al.
Published: (2021-05-01)

Evaluation of clinical risk factors for systemic antimony treatment failure in patients with acute cutaneous leishmaniasis referred to dermatology clinics of Mashhad University of Medical Sciences, Iran
by: Yalda Nahidi, et al.
Published: (2023-10-01)

Effect of Antimonial Therapy on Levels of (TNF-α and IL-1β) Cytokines in Cutaneous Leishmaniasis Patients in Iraq
by: Hasan Raheem Khudhur, et al.
Published: (2019-12-01)

Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensis
by: Juliana Figueiredo Peixoto, et al.
Published: (2024-04-01)

Treatment of leishmaniasis with chemotherapy and vaccine: a mathematical model
by: Nourridine Siewe, et al.
Published: (2023-12-01)

FIRST REPORT ON OTOTOXICITY OF MEGLUMINE ANTIMONIATE
by: Cláudia Maria Valete-Rosalino, et al.
Published: (2014-09-01)

<i>In Vivo</i> Evaluation of Sepigel-Based Meglumine Antimoniate and Amphotericin B for Cutaneous Leishmaniasis Treatment
by: Atteneri López-Arencibia, et al.
Published: (2024-08-01)

Study of the Effectiveness of Drugs for the Treatment of Zoonotic Cutaneous Leishmaniasis in vivo on a Laboratory Model
by: Yu. K. Kuznetsova
Published: (2020-05-01)

Imported Cutaneous Leishmaniasis from Peru Caused by <i>Leishmania (Viannia) guyanensis</i> in a Brazilian Patient: Case Report and In Vitro Drug Susceptibility Analysis
by: Elizabeth M. Coser, et al.
Published: (2024-11-01)

Cutaneous leishmaniasis in cats (Felis domesticus) caused by Leishmania (Leishmania) venezuelensis
by: Rafael Bonfante Garrido, et al.
Published: (2010-07-01)

Epidemiological Study of Cutaneous Leishmaniasis in Kermanshah Province, 2011-2019
by: Ameneh Asadi, et al.
Published: (2022-09-01)

Improved Treatment Outcome Following the Use of a Wound Dressings in Cutaneous Leishmaniasis Lesions
by: Pedro B. Borba, et al.
Published: (2024-05-01)

Outbreak of cutaneous leishmaniasis in the Rio Doce Valley, Minas Gerais, Brazil
by: Marco Victor Hermeto, et al.
Published: (1994-12-01)

study of the prevalence of cutaneous leishmaniasis in south-east part of Kashan
by: A Dorudgar, et al.
Published: (1996-03-01)

Effect of Pentoxifylline on Human Sperm Preparation
by: Roungsin Choavaratana, et al.
Published: (2003-09-01)